{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T14:50:14Z","timestamp":1783695014828,"version":"3.55.0"},"reference-count":20,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T00:00:00Z","timestamp":1703808000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"national institutes of health","doi-asserted-by":"publisher","award":["5R01DA044167, 5R01HS026753 and 1R01DA058315"],"award-info":[{"award-number":["5R01DA044167, 5R01HS026753 and 1R01DA058315"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Substance Use &amp;amp; Addiction Journal"],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>Telehealth treatment with medication for opioid use disorder (teleMOUD) was made possible with regulations following the COVID-19 pandemic that permitted prescribing buprenorphine without an in-person visit. This study evaluates the self-reported outcomes of patients treated by teleMOUD using the Brief Addiction Monitor (BAM), a 17-question tool that assesses drug use, cravings, physical and psychological health, and psychosocial factors to produce 3 subset scores: substance use, risk factors, and protective factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Patients treated by a teleMOUD provider group operating in &gt;30 states were asked to complete an app-based version of BAM at enrollment and at 1\u2009month. Patients who completed both assessments between June 2022 and March 2023 were included.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>A total of 2556 patients completed an enrollment BAM and 1447 completed both assessments. Mean number of days from baseline BAM to follow-up was 26.7\u2009days. Changes were significantly different across most questions. The substance use subscale decreased from mean 2.6 to 0.8 ( P\u2009&lt;\u2009.001), the risk factors subscale decreased from mean 10.3 to 7.5 ( P\u2009&lt;\u2009.001), and the protective factors subscale increased from mean 14.3 to 15.0. ( P\u2009&lt;\u2009.001). Substance use and risk factor subscale changes were significant across all sex and age groups, while protective factors subscale did not improve for those &lt;25 and &gt;54\u2009years. Patient reports of at least 1\u2009day of illegal use or misuse decreased, including marijuana (28.1% vs 9.0%), cocaine\/crack (3.9% vs 2.6%), and opioids (49.8% vs 10.5%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Among patients treated by teleMOUD who completed assessments at enrollment and 1\u2009month, there was improvement in drug use, risk factor, and protective factor scores.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/29767342231212790","type":"journal-article","created":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T05:08:09Z","timestamp":1703826489000},"page":"16-23","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":4,"title":["An Assessment of the One-Month Effectiveness of Telehealth Treatment for Opioid Use Disorder Using the Brief Addiction Monitor"],"prefix":"10.1177","volume":"45","author":[{"given":"Barbara","family":"Burke","sequence":"first","affiliation":[{"name":"Bicycle Health, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Clear","sequence":"additional","affiliation":[{"name":"Bicycle Health, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebekah L.","family":"Rollston","sequence":"additional","affiliation":[{"name":"Bicycle Health, Boston, MA, USA"},{"name":"Department of Medicine, Cambridge Health Alliance, Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily N.","family":"Miller","sequence":"additional","affiliation":[{"name":"Bicycle Health, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4672-5184","authenticated-orcid":false,"given":"Scott G.","family":"Weiner","sequence":"additional","affiliation":[{"name":"Bicycle Health, Boston, MA, USA"},{"name":"Department of Emergency Medicine, Brigham and Women\u2019s Hospital, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2023,12,29]]},"reference":[{"issue":"1","key":"bibr1-29767342231212790","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s11606-021-07174-w","volume":"37","author":"Huskamp HA","year":"2022","journal-title":"J Gen Intern Med"},{"key":"bibr2-29767342231212790","unstructured":"Department of Health and Human Services. Practice guidelines for the administration of buprenorphine for treating opioid use disorder. 2021. Accessed October 8, 2023. https:\/\/www.govinfo.gov\/content\/pkg\/FR-2021-04-28\/pdf\/2021-08961.pdf"},{"issue":"6","key":"bibr3-29767342231212790","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/ADM.0000000000001006","volume":"16","author":"Sousa JL","year":"2022","journal-title":"J Addict Med"},{"issue":"1","key":"bibr4-29767342231212790","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.52381","volume":"6","author":"Hailu R","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"10","key":"bibr5-29767342231212790","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1176\/appi.ajp.21111141","volume":"179","author":"Lin LA","year":"2022","journal-title":"Am J Psychiatry"},{"issue":"10","key":"bibr6-29767342231212790","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.36298","volume":"5","author":"Frost MC","year":"2022","journal-title":"JAMA Netw Open"},{"key":"bibr7-29767342231212790","doi-asserted-by":"crossref","first-page":"108492","DOI":"10.1016\/j.jsat.2021.108492","volume":"133","author":"Lin LA","year":"2022","journal-title":"J Subst Abuse Treat"},{"issue":"10","key":"bibr8-29767342231212790","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1001\/jamapsychiatry.2022.2284","volume":"79","author":"Jones CM","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"bibr9-29767342231212790","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2013.07.002"},{"issue":"3","key":"bibr10-29767342231212790","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jsat.2012.07.013","volume":"44","author":"Cacciola JS","year":"2013","journal-title":"J Subst Abuse Treat"},{"key":"bibr11-29767342231212790","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1136\/bmjinnov-2021-000816","volume":"8","author":"Rollston R","year":"2022","journal-title":"BMJ Innov"},{"key":"bibr12-29767342231212790","unstructured":"U.S. Department of Veterans Affairs. Brief addiction monitor (BAM) with scoring & clinical guidelines (draft). 2009. Accessed October 8, 2023. https:\/\/www.mentalhealth.va.gov\/providers\/sud\/docs\/BAM_Scoring_Clinical_Guidelines_01-04-2011.pdf"},{"issue":"5","key":"bibr13-29767342231212790","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1001\/jamapsychiatry.2023.0310","volume":"80","author":"Jones CM","year":"2023","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"bibr14-29767342231212790","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1080\/10826084.2023.2177111","volume":"58","author":"Young GJ","year":"2023","journal-title":"Subst Use Misuse"},{"key":"bibr15-29767342231212790","doi-asserted-by":"crossref","first-page":"100489","DOI":"10.1016\/j.lanepe.2022.100489","volume":"22","author":"Domzaridou E","year":"2022","journal-title":"Lancet Reg Health Eur"},{"issue":"2","key":"bibr16-29767342231212790","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1080\/00952990.2023.2180382","volume":"49","author":"Williams AR","year":"2023","journal-title":"Am J Drug Alcohol Abuse"},{"key":"bibr17-29767342231212790","doi-asserted-by":"crossref","first-page":"108849","DOI":"10.1016\/j.jsat.2022.108849","volume":"141","author":"LaForge K","year":"2022","journal-title":"J Subst Abuse Treat"},{"key":"bibr18-29767342231212790","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2023.0234"},{"issue":"3","key":"bibr19-29767342231212790","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1037\/pas0000973","volume":"33","author":"Hallinan S","year":"2021","journal-title":"Psychol Assess"},{"key":"bibr20-29767342231212790","doi-asserted-by":"crossref","first-page":"100125","DOI":"10.1016\/j.dadr.2022.100125","volume":"5","author":"Schumm J","year":"2022","journal-title":"Drug Alcohol Depend Rep"}],"container-title":["Substance Use &amp;amp; Addiction Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/29767342231212790","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/29767342231212790","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/29767342231212790","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T01:48:57Z","timestamp":1777600137000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.sagepub.com\/doi\/10.1177\/29767342231212790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,29]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["10.1177\/29767342231212790"],"URL":"https:\/\/doi.org\/10.1177\/29767342231212790","relation":{},"ISSN":["2976-7342","2976-7350"],"issn-type":[{"value":"2976-7342","type":"print"},{"value":"2976-7350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,29]]}}}